Welcome to Evonik Healthcare

Evonik launches RESOMER® Precise platform of custom functional excipients to precisely control the release profile of parenteral drug products

A worldwide presence from strain development to large-scale production

EUR 25 million first stage expected to be completed by mid-2021 as COVID-19 pandemic highlights need for more European capacity

Order our cQrex®️ sample kit combining dipeptides and a keto acid to determine how you can optimize the stability and solubility of media ingredients to improve the performance of media and processes. Email us at [email protected] to request a kit now.

EUDRACAP functional ready-to-fill capsules can optimize your release profile, protect your active ingredients, and help accelerate your speed to market.

Excellence in polymer chemistry applied to pharmaceutical applications

 Custom tailored high quality PEG specialties meeting the highest standards

The world’s largest HPAPI capacity

Key market trends driving demand for the use of advanced technologies in the chemical synthesis of complex small molecules.

A modular aseptic filling platform for complex and personalized parenteral drug products in powder, liquid, suspension or combination form.

Developing a delayed release formulation of acid-sensitive actives that can be used in solid dosage forms such as tablets, pellets and capsules can be costly. Usually several stages are involved starting from R&D development to scale up and validation steps, all of which require significant investment of time and money. Sourcing a ready-to-fill functional capsule is an effective way of saving costs, reducing time to market, and boosting the performance of oral drug delivery products. EUDRACAP is our recently launched non-animal-derived platform of functional, ready-to-fill capsules for fast-track development of sensitive drugs.

At Evonik, there are more than 32,000 of us. In over 100 countries. Every one of us is a specialist in our own field. But there is one thing we all have in common: We think beyond the bounds of chemistry ... to make the world a better place day by day. Today and tomorrow. We are the future of chemistry. We are Evonik.

Chemistry in Water is a green technology that allows classical organic reactions often used in the synthesis of active pharmaceutical ingredients and intermediates to be carried out in water. Based on pioneering micellar technology, developed by Professor Bruce Lipshutz of the University of California, Santa Barbara, Evonik offers this highly sustainable technology for the industrial scale production of pharma intermediates and APIs.